AUROBINDO PHARMA LTD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO PHARMA LTD, and what generic and branded alternatives to AUROBINDO PHARMA LTD drugs are available?
AUROBINDO PHARMA LTD has two hundred and twenty-two approved drugs.
There are fifteen tentative approvals on AUROBINDO PHARMA LTD drugs.
Summary for AUROBINDO PHARMA LTD
| US Patents: | 0 |
| Tradenames: | 183 |
| Ingredients: | 176 |
| NDAs: | 222 |
| Drug Master File Entries: | 237 |
| Patent Litigation for AUROBINDO PHARMA LTD: | See patent lawsuits for AUROBINDO PHARMA LTD |
Drugs and US Patents for AUROBINDO PHARMA LTD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | CEFPODOXIME PROXETIL | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 065409-002 | Jun 8, 2007 | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Aurobindo Pharma Ltd | TAMSULOSIN HYDROCHLORIDE | tamsulosin hydrochloride | CAPSULE;ORAL | 202433-001 | Apr 30, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Aurobindo Pharma Ltd | AZITHROMYCIN | azithromycin | FOR SUSPENSION;ORAL | 209201-002 | Oct 9, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Aurobindo Pharma Ltd | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | TABLET;ORAL | 213286-001 | Apr 8, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Aurobindo Pharma Ltd | MYCOPHENOLATE MOFETIL | mycophenolate mofetil | CAPSULE;ORAL | 217828-001 | Jan 5, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Aurobindo Pharma Ltd | LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 201043-002 | Jun 20, 2011 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Aurobindo Pharma Ltd | RAMIPRIL | ramipril | CAPSULE;ORAL | 091604-001 | Jun 8, 2011 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
